Alcon
ALC
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
2
In their latest 13F (Q3 2026)
See who
Value held
$860m
Combined value at quarter end
Last quarter
2 bought
1 sold or trimmed
Price at Q2 ’26 end
$60.96
-18.3% in the quarter
Share price change by quarter
+12.1%Q3 ’24
-15.1%Q4 ’24
+11.6%Q1 ’25
-6.8%Q2 ’25
-15.7%Q3 ’25
+5.8%Q4 ’25
-5.3%Q1 ’26
-18.3%Q2 ’26
Managers holding it, by quarter
2Q4 ’23
2Q1 ’24
2Q2 ’24
2Q3 ’24
2Q4 ’24
2Q1 ’25
2Q2 ’25
3Q3 ’25
3Q4 ’25
3Q1 ’26
2Q2 ’26
0Q3 ’26
Who holds it
| AKO Capital | 15.2%$652m | Added +3.8% |
| Troy Asset Management | 5.8%$208m | Added +27% |
About the company
- Sector
- Health care · Ophthalmic Goods
- Financial year ends
- 31 December
- Shares outstanding
- 487m at 31 Dec 2025
- SEC filings
- Annual reports and other filings on EDGAR
Sold out last quarter
- Cantillon Capital Management in Q2 2026